Filing Details
- Accession Number:
- 0001140361-11-046727
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-22 17:56:31
- Reporting Period:
- 2011-09-20
- Filing Date:
- 2011-09-22
- Accepted Time:
- 2011-09-22 17:56:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1379006 | Nanoviricides Inc. | NNVC.OB | Services-Commercial Physical & Biological Research (8731) | 760674577 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1513285 | Anil Diwan | 135 Wood Street, Suite 205 West Haven CT 06516 | President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-09-20 | 5,000 | $1.12 | 6,955,350 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-09-21 | 15,000 | $1.11 | 6,940,350 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Does not include 33,360,000 shares of common stock held by TheraCour Pharma, Inc., of which Anil Diwan holds voting and dispositive power.